14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $43.33 $52.87 Friday, 3rd May 2024 BMY stock ended at $43.99. This is 0.664% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 1.48% from a day low at $43.69 to a day high of $44.33.
90 days $43.33 $55.03
52 weeks $43.33 $69.10

Historical Bristol-Myers Squibb Company prices

Date Open High Low Close Volume
Jan 17, 2024 $49.55 $50.07 $48.95 $49.98 16 404 747
Jan 16, 2024 $50.30 $50.47 $49.82 $50.00 13 761 941
Jan 12, 2024 $50.39 $50.71 $50.07 $50.31 11 171 309
Jan 11, 2024 $50.65 $50.74 $50.01 $50.22 16 318 430
Jan 10, 2024 $51.20 $51.25 $50.42 $50.66 14 489 605
Jan 09, 2024 $52.05 $52.10 $51.23 $51.28 13 303 721
Jan 08, 2024 $51.89 $51.89 $51.29 $51.79 13 150 819
Jan 05, 2024 $51.91 $52.57 $51.65 $52.23 11 955 727
Jan 04, 2024 $51.91 $52.18 $51.46 $52.04 14 605 980
Jan 03, 2024 $52.70 $52.90 $51.47 $52.30 15 507 951
Jan 02, 2024 $51.45 $53.45 $51.40 $52.76 17 799 560
Dec 29, 2023 $51.13 $51.49 $50.99 $51.31 9 027 777
Dec 28, 2023 $51.05 $51.45 $51.00 $51.22 10 578 334
Dec 27, 2023 $51.41 $51.50 $50.75 $51.21 13 152 546
Dec 26, 2023 $52.41 $52.77 $51.06 $51.45 12 193 080
Dec 22, 2023 $50.86 $53.48 $50.86 $52.29 19 673 564
Dec 21, 2023 $51.34 $51.74 $50.85 $51.26 12 573 267
Dec 20, 2023 $52.03 $52.24 $50.94 $50.96 10 708 580
Dec 19, 2023 $51.61 $52.18 $51.46 $52.11 13 609 161
Dec 18, 2023 $51.15 $51.49 $50.93 $51.34 10 238 594
Dec 15, 2023 $51.16 $51.45 $50.69 $50.89 14 296 559
Dec 14, 2023 $52.46 $52.54 $51.00 $51.47 17 749 641
Dec 13, 2023 $50.07 $51.86 $49.95 $51.86 14 374 915
Dec 12, 2023 $50.80 $50.94 $49.80 $50.51 9 172 551
Dec 11, 2023 $50.52 $51.14 $50.27 $51.09 17 257 308
Click to get the best stock tips daily for free!

About Bristol-Myers Squibb Company

Bristol-Myers Squibb Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for th... BMY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT